Savaria Co. (TSE:SIS) Receives C$33.33 Consensus PT from Brokerages

Savaria Co. (TSE:SISGet Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last year is C$33.33.

Several research firms recently commented on SIS. Stifel Nicolaus lifted their price objective on Savaria from C$29.00 to C$31.00 and gave the stock a “buy” rating in a report on Wednesday, April 8th. Desjardins upped their target price on shares of Savaria from C$32.00 to C$35.00 and gave the company a “buy” rating in a research note on Thursday, April 16th. Scotia raised their price target on shares of Savaria from C$30.00 to C$33.00 and gave the company a “sector outperform” rating in a report on Thursday, April 16th. ATB Cormark Capital Markets lifted their price target on shares of Savaria from C$32.00 to C$35.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Finally, TD boosted their price objective on shares of Savaria from C$31.00 to C$35.00 and gave the company a “buy” rating in a report on Wednesday, April 15th.

View Our Latest Report on Savaria

Insider Activity at Savaria

In other news, Director Jean-Louis Chapdelaine sold 25,000 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of C$27.73, for a total value of C$693,250.00. Following the transaction, the director directly owned 100,000 shares in the company, valued at C$2,773,000. This trade represents a 20.00% decrease in their position. Also, Director Marcel Bourassa sold 7,500 shares of Savaria stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of C$29.53, for a total value of C$221,475.00. Following the completion of the sale, the director directly owned 225,431 shares of the company’s stock, valued at C$6,656,977.43. The trade was a 3.22% decrease in their position. In the last 90 days, insiders sold 62,500 shares of company stock worth $1,761,124. Company insiders own 17.45% of the company’s stock.

Savaria Stock Performance

SIS stock opened at C$30.66 on Friday. The stock has a market capitalization of C$2.20 billion, a PE ratio of 27.87, a price-to-earnings-growth ratio of 42.72 and a beta of 1.03. Savaria has a 12-month low of C$19.25 and a 12-month high of C$30.67. The company has a current ratio of 1.71, a quick ratio of 0.91 and a debt-to-equity ratio of 31.42. The stock’s 50 day simple moving average is C$28.94 and its 200 day simple moving average is C$26.71.

Savaria (TSE:SISGet Free Report) last posted its earnings results on Wednesday, May 6th. The company reported C$0.31 EPS for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%.The business had revenue of C$235.55 million during the quarter. As a group, research analysts forecast that Savaria will post 1.2048518 earnings per share for the current fiscal year.

Savaria Company Profile

(Get Free Report)

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

Featured Articles

Analyst Recommendations for Savaria (TSE:SIS)

Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.